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The quantitative relations between serum creatine ki-
nase-Mll isoenzyme (CK·MB) release and the final in-
farct size estimated by myocardial emission computed
tomography with thallium-201 was assessed in 37 pa-
tients with a first acute transmural myocardial infarction
who underwent intracoronary thrombolysis using uro-
kinase 4.6 ± 1.9 hours after the onset of symptoms.
Serial CK-MB determinations were used to calculate the
accumulated release ofCK-MB (ICK·MB). Myocardial
emission tomography with thallium-201 was performed
4 weeks after the onset, and infarct volume was mea-
sured from reconstructed tomographic images by com-
puterized planimetry. The results are presented for two
groups of patients: 11 patients with unsuccessful throm-
bolysis (group A) and 26 patients with successful throm-
bolysis (group B). An excellent linear relation was found
for group A <ICK-MB =6.4 x infarct volume + 47.7,
Serial serum creatine kinase (CK) and serum CK-MB iso-
enzyme activity determinations have been widely used for
the noninvasive estimation of myocardial infarct size (1- 9).
Recentl y, rapid recanali zation of the acutely occluded coro-
nary artery was establi shed with use of intracoronary in-
fusion of thrombolytic agent s (10-16) and rapid appearance
of CK in blood after successful thrombolysis was noted in
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r = 0.91), whereas a different linear relation was ob-
served for group B (ICK·MB = 10.5 x infarct volume
+ 89.1, r = 0.80). Moreover, serum CK·MB activity
reached a peak at 21.1 ± 2.2 hours after the onset in
group A and reached an earlier peak at 12.5 ± 2.9 hours
in group B (p < 0.001).
These data suggest that acute coronary recanalization
alters the kinetics of CK·MB release, resulting in greater
CK-MB release into the serum for equivalent infarct
volume estimated by myocardial emission tomography
with thallium-201. Thus , serum CK-MB time-activity
curves after acute myocardial infarction may be influ-
enced considerably by acute reperfusion , which is an
important factor that should be incorporated in the
interpretation of enzymatic estimates of infarct size in
human patients.
several clinical studies (11.12. 15, 16). The early appearance
of increased serum enzyme levels after reperfusion has al-
ready been reported in experimental animal studies (17) .
Moreover . experimental studies (18.19) have suggested that
the total amount of CK that is released into blood after
coronary artery reperfusion may be much greater than ex-
pected for the pathologically determined infarct size . In the
clinical setting, however , the quantitative relation between
enzyme level and the final size of infarcted myocard ium
after successful recanalization has not yet been clarified .
Because early coronary artery recanalization with throm-
bolytic agents is finding increasing use in medical practice,
a clear understanding of the effects of thrombolysis on the
kinetics of enzyme release is needed . Although there is no
well establi shed standard for quantifying infarct size in liv-
ing patients. there is evidence that thallium-201 myocardial
0735-1097/83/$3.00
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scintigraphy is valid for determining infarct size in human
subjects (7,20-25).
In this study, myocardial emission computed tomography
with thallium-201 was used to estimate the final size of
infarcted myocardium. The purpose of our study was to
assess the effect of acute coronary artery recanalization on
the relation between serum CK-MB release and infarct size
estimated by myocardial emission tomography with thal-
lium-201 in patients with acute myocardial infarction who
underwent intracoronary thrombolysis .
Methods
Study patients. The study group comprised 37 patients
with a first acute transmural myocardial infarction, in whom
intracoronary infusion with urokinase was performed in or-
der to recanalize the obstructed coronary artery during the
acute stage of infarction . These patients were selected from
a consecutive series of 46 patients who underwent intra-
coronary thrombolysis from September 1981 to April 1983
on the basis of the following criteria: I) the patient had a
first acute transmural myocardial infarction with neither
clinical nor electrocardiographic evidence of a previous in-
farction ; 2) there was no recurrence of myocardial infarction
after the completion of enzyme sampling until the time of
scintigraphic imaging ; and 3) myocardial emission tomog-
raphy with thallium-2Ot could be performed 4 weeks after
the onset of infarction. Two of the remaining nine patients
died during the acute phase of their disease and, therefore ,
scintigraphic study could not be performed. Five patients
had a previous myocardial infarction and two patients had
a recurrence of infarction diagnosed by a rise of CK-MB
levels until the scintigraphic study.
The diagnosis ofacute transmural myocardial infarction
was based on acute onset of chest pain lasting for more than
30 minutes and persistent ST segment elevation lasting for
more than 30 minutes and progressing to new Q waves of
greater than 0.04 second duration in the standard 12 lead
electrocardiogram. Diagnosis was subsequently confirmed
by electrocardiographic evolutionary changes and positive
CK-MB determinations. Patients who had symptoms for
more than 10 hours before entry into the coronary care unit
were excluded from the study . All patients gave written
informed consent after detailed explanation of the proce-
dure, its possible hazards and possible beneficial effects.
Coronary reperfusion technique. Selective coronary
angiography was performed by either the femoral or brachial
artery approach. After occlusion of the coronary artery was
confirmed, sublingual or intracoronary nitroglycerin (0.2 to
0.4 mg) was administered. Angiography was again per-
formed I to 2 minutes later to exclude spastic occlusion. If
no change in the angiographic appearance of the vessel was
noted, urokinase dissolved in saline solution was infused
into the occluded coronary artery through the coronary cath-
eter at a rate of 24,000 units/min. The mean interval from
the onset of chest pain to infusion of urokinase was 4.6 ±
I. 9 hours (range 2 to 8.5 ). Coronary angiography was re-
peated at 5 minute intervals during the infusion of urokinase
and the infusion was stopped 5 minutes after recanalization
of the occluded vessel. If the coronary vessel was not re-
opened after infusion of 840 ,000 units of urokinase, no
further attempt was made . After completion of cardiac cath-
eterization, patients were transferred to the coronary care
unit.
Calculation of CK-MB released into serum. Blood
samples were obtained immediately after admission, before
the urokinase infusion, at 30 minutes and at I hour after
recanalization of the occluded vessel and every 4 hours for
the following 48 hours. Specimens were collected and im-
mediately centrifuged to separate the serum, which was
stored at -70°C. CK-MB isoenzyme activity was separated
from sera by Diethyl-aminoethyl-Sephalose column chro-
matography using minicolumns (26). Enzyme activity of
the column eluate was determined according to the method
of Rosalki (27) . A computer was used to generate each
serum CK-MB time-activity curve, to fit an exponential to
the downslope of the curve using the least squares method
and derive an individual disappearance constant (Kd) of CK-
MB from serum for each patient. The accumulated release
of CK-MB (lCK-MB) was calculated using a modification
(3,4) of the original formula of Shell et al. (l ,2). lCK-MB
represents the total amount of CK-MB that would appear
in the serum in the absence of enzyme disappearance . The
peak level of CK-MB was also noted for each patient.
Myocardial emission computed tomography with
thallium-201. Myocardial tomograms were obtained 4 weeks
after the onset of myocardial infarction, when the patient's
condition had stabilized . Each patient received 2 mCi of
thallium-201 at rest and underwent imaging 10 minutes later
with a large field of view gamma camera equipped with a
high resolution parallel-hole collimator supported by a gan-
try (General Electric Maxi-400T) . Sixty-four different views
over 360°, 20 seconds each, provide sampling for every 5.8°
of revolution of the detector. Transaxial tomograms were
reconstructed into 12 mm thick multiple slices by a filtered
back-projection method with Chesler's filter (28) using a
convolution reconstruction algorithm (7,29). Attenuation
correction was performed by Sorenson ' s method (30) . It
took the computer (PDP II , Digital Equipment Corporation)
20 seconds to reconstruct each transaxial slice, which was
displayed perpendicular to the long axis of the left ventricle .
Thereafter, frontal and sagittal tomograms were organized
from a series of transaxial tomograms, so that the frontal
and sagittal tomograms closely corresponded to the cross
section and longitudinal section in relation to the cardiac
axis, respectively (7,29). Each reconstructed slice contained
lACC Vol 2, No 6
December 1983 1031-8
TAMAKI ET AL
REPERFUSION ANDCREATINE KINASE-MB RELEASE
1033
150,000 to 200,000 counts, The reconstructed images were
displayed in a 64 X 64 matrix.
To estimate the size of the perfusion defect, we analyzed
the tomograms in the most appropriate section that showed
the defect transversely, selecting transaxial sections in the
anterior myocardial infarct and frontal sections in the in-
ferior infarct. Our method to measure the size of the per-
fusion defect from tomographic images has been described
in detail previously (7). Briefly, after each image was sub-
tracted by 45% of the maximal radioactivity, the myocardial
contour was outlined with a light pen and the area showing
the defect was measured by computerized planimetry. A
defect region was defined as one with thallium-201 uptake
less than 45% of the maximal uptake in any image element
(Fig. I). The number of image elements occupied by per-
fusion defects in all reconstructed slices was multiplied by
the size factor (0.432 ml per image element) to determine
the volume of infarcted myocardium. Infarct volume was
expressed in milliliters. Thallium-201 myocardial tomo-
grams were assessed independently by two of us, neither
of whom had prior knowledge of the results of the enzymatic
analysis.
The reproducibility ofthe quantitative tomographic anal-
ysis by these methods described was also tested in 37 pa-
tients. When the same observer recalculated the same data
in 37 patients 1 month later, the intraobserver variation in
measurement of infarct volume was 1.8 ± 1.3 ml (range
0.3 to 5.0), When a second observer performed these 37
studies without knowledge of the results of the first observer,
the interobserver variation was 2.1 ± 2.0 ml (range 0.4 to
8.1) for calculations of infarct volume.
Statistical analysis. We found linear correlations by the
method of least squares analysis and used the unpaired t
test to assess differences between groups of unpaired data.
A probability (p) value of less than 0.05 was considered
Figure 1. Method of assessing size of thallium-201 perfusion
defect. After the outer and inner myocardial contours of each
myocardial section were outlined with a light pen, the area showing
the perfusion defect was measured by computenzed planimetry.
significant. Data are expressed as mean ± 1 standard
deviation.
Results
Patient groups (Table 1). Thirty-seven patients met the
previously described criteria and were included in the study.
Thirty-three were men and four were women. Their mean
age was 59 years (range 39 to 77). The patients were clas-
sified into two groups. Group A consisted of 11 patients in
whom the attempt to recanalize the occluded coronary artery
failed (unsuccessful thrombolysis) and group B consisted
of 26 patients with reopening of the occluded coronary artery
after intracoronary infusion of urokinase (successful throm-
bolysis). All patients in group A had total occlusion of the
infarct-related coronary artery and the total occlusion re-
mained unchanged even after intracoronary urokinase in-
fusion. The occluded vessel was the right coronary artery
in four patients and the left anterior descending coronary
artery in seven patients. In group B before thrombolysis, 22
patients had total occlusion of the infarct-related vessel and
reopening of occlusion after urokinase infusion. The re-
maining four patients had subtotal occlusion of the infarct
vessel with sluggish flow and improved runoff after intra-
coronary urokinase administration. The occluded vessel was
the right coronary artery in 6 patients, the left circumflex
coronary artery in 2 patients and the left anterior descending
coronary artery in 18 patients. Recanalization was achieved
5.3 ± 2.0 hours after the onset of symptoms. Adequate
collateral supply to the occluded vessel was observed in one
patient in group A and in two patients in group B. The time
interval between the onset of symptoms and initiation of
intracoronary urokinase infusion was 4.3 ± 1.7 hours in
group A and 4.7 ± 1.9 hours in group B (difference not
significant) .
All patients were treated medically after intracoronary
thrombolysis. One patient in group A had congestive heart
failure, which required afterload-reducing agents in addition
to diuretic drugs. Two patients in group B had postinfarction
angina but responded well to medical therapy. The remain-
ing 34 patients did not have chest pain or exhibit signs of
heart failure during the hospitalization after the acute in-
tervention. No patient in group A or B had enzymatic or
electrocardiographic evidence of recurrence of acute myo-
cardial infarction between the acute intervention and the late
scintigraphic study. All patients were in stable condition
when scintigraphic imaging was performed.
Serum CK·MB kinetics (Fig. 2 and 3). Serum CK-
MB time-activity curves in patients in group B (successful
thrombolysis) differed from those in patients in group A
(unsuccessful thrombolysis). In group A, serum CK-MB
activity increased gradually to a peak at 21.1 ± 2.2 hours
after the onset of the infarct (Fig. 2). In contrast, in group
B serum CK-MB activity increased sharply immediately
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Figure 2. Serum CK-MB time-activity curve (top) and the thal-
lium-20l myocardial tomograms (bottom) from Patient 2 with
unsuccessful thrombolysis (group A). The arrow indicates the
timing of intracoronary thrombolysis. In the tomograms, transaxial
sections proceed from head (left) to foot (right) , frontal sections
proceed from apex (left) to base (right) and sagittal sections pro-
ceed from septal (left) to lateral region (right) . The infarct volume
estimated by myocardial emission tomography in this patient was
24 ml, CK-MB = creatine kinase-MB isoenzyme activity; ICK-
MB = the accumulated release of CK-MB.
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Figure 3. Serum CK-MB time-activity curve (top) and the thal-
lium-201 myocardial tomograms (bottom) obtained in Patient 25
with successful thrombolysis (group B). The arrow indicates the
timing of intracoronary thrombolysis . Despite greater ICK-MB,
the size of thallium-201 perfusion defects in the inferior wall seen
on tomograms from this patient (12 ml) is smaller than that (24
ml) in Patient 2. Abbreviations as in Figure 2.
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after recanalization and reached a peak at 12.5 ± 2.9 hours
after the onset (Fig. 3), occurring significantly earlier than
in group A (p < 0.(01) . There were no significant group
differences in !CK-MB (group A, 233.0 ± 120.4 Ill/liter,
group B, 304.5 ± 186.9 IV/liter) and Kd (group A, -85 .2
± 18.4 X 10- 3 hour ~ I ; group B, - 86.8 ± 19.1 X 10- 3
hour- I) (Table I).
Relation between CK-MB release and infarct size es-
timated by myocardial emission tomography with thal-
lium-2ot (Fig. 4). An excellent linear relation between
!CK-MB and infarct volume estimated by myocardial emis-
sion tomography with thallium-201 was observed in group
A (unsuccessful thrombolysis) (!CK-MB = 6.4 X infarct
volume + 47.7 , correlation coefficient [r) = 0.91 , standard
error of the estimate [SEE) = 55.7, P < 0.001). On the
other hand, the relation remained linear but it was shifted
upward in group B (successful thrombolysis) (!CK-MB =
10.5 x infarct volume + 89.1, r = 0.80, SEE = 116.3,
p < 0.001) . The slope was steeper than observed for pa-
tients in group A, suggesting that more CK-MB appeared
in serum per unit of infarcted myocardium after successful
thrombolysis . This is supported by the observation that the
average ratio of !CK-MB to infarct volume estimated by
myocardial emission tomography with thallium-201 (16.1
± 6.8) was significantly greater than in patients in group
A (8.6 ± 2.2) (p < 0.01), although alternations of the ratio
of !CK-MB to infarct volume had a wide variation.
Representative thallium-201 tomographic images from
one patient in group A (Patient 2) and one in group B (Patient
25) are shown in Figures 2 and 3, respectively. Both had
inferior myocardial infarction. Despite greater !CK-MB,
the size of the inferior wall perfusion defects seen on tom-
ograms from Patient 25 (successful thrombolysis) was smaller
than that in Patient 2 (unsuccessful thrombolysis).
lACC Vol. 2, No.6
December 1983'1031-8
TAMAKI ET AL.
REPERFUSION AND CREATINE KINASE-MB RELEASE
1035
Table 1. Clinical, Enzymatic and Scintigraphic Data in 37 Patients
Time to Infarct Volume
Age (yr) Infarct Vessel! Peak CK-MB Kd LCK-MB Based on
Case & Sex Residual Stenosis (%) (h) (XIO- 3h-') (lU/liter) Tl-2OI ECT (mil
Group A. Panents With Unsuccessful Thrombolysis
I 58M LAD/IOO 225 -639 262 26
2 60M RCA/IOO 23.5 -72.0 121 24
3 60M LADIIOO 17.0 -78.1 160 18
4 51M RCA/100 22.0 -62.1 161 12
5 50M LAD/100 22.0 -96.6 330 40
6 69M LAD/100 175 -90.8 341 38
7 5lM RCA/IOO 235 -1240 189 21
8 69F LAD/100 190 -86.3 479 74
9 56M LAD/100 21.0 -69.4 46 7
10 48M LAD/100 220 -84.8 145 27
II 58F RCA/IOO 22.0 -1092 329 31
Mean 57.3 21.1 -85.2 233.0 28.9
± SD 6.8 2.2 18.4 120.4 17.1
Group B. Patients With Successful Thrombolysis
12 53M LAD/99 12.0 -115.0 399 24
13 48M RCA175 17.0 -87.1 654 18
14 63F LAD/90 14.5 -91.6 311 30
15 62M LAD/99 16.0 -115.0 405 28
16 49M LAD/99 15.0 -63.1 224 26
17 60M LAD/90 14.5 -69.3 617 43
18 63M LCx/99 I I 5 -72.1 117 II
19 59M LAD/99 8.0 -63.2 190 20
20 73M LAD/90 15.5 - 112.0 174 8
21 58M LAD/90 14.0 -103.4 446 16
22 17M RCA/99 8.0 -85.2 52 6
23 51M RCA/90 12.0 -60.8 313 21
24 51M LAD/99 10.0 -79.0 204 15
25 66F RCAI75 10.0 -127.0 306 12
26 63M LAD/50 9.5 -86.4 243 18
27 54M LAD190 16.0 -64.5 56 5
28 74M RCA/90 14.5 -68.1 318 24
29 70M LAD/90 14.0 -77.0 222 13
30 53M LADI75 8.0 -106.7 132 5
31 62M LCx/90 10.0 -111.1 363 17
32 57M RCA/99 80 -88.1 208 25
33 47M LAD/50 150 -79.4 192 9
34 39M LAD/90 9.0 -81.3 371 30
35 54M LAD/90 15.0 -109.1 62 5
36 60M LAD/90 16.0 -74.6 794 74
37 66M LAD/99 11.5 -67.5 483 30
Mean 59.2 12.5* -86.8 304.5 20.5
± SD 9.1 2.9 19.1 186.9 14.3
*Significantly different from group A (p < 0.001). CK-MB = creatine kinase-MB isoenzyme; F = female; Kd = disappearance constant; LAD =
left anterior descending coronary artery; LCx = left circumflex coronary artery; M = male; RCA = right coronary artery; SD = standard deviation;
LCK-MB = the accumulated release of CK-MB; Tl-201 ECT = myocardial emission tomography with thallium-2OI
Although infarct volume estimated by myocardial emis-
sion tomography with thallium-20l showed marked varia-
bility in both groups, there was no significant group dif-
ference in infarct volume (group A, 28.9 ± 17.1 ml, range
7 to 74; group B, 20.5 ± 14.3 ml, range 5 to 74)
(Table 1).
Discussion
Previous studies relating creatine kinase (CK) and
CK-MB release to infarct size. Of the methods available
for living patients, quantification of the release of CK by
serial serum sampling is a widely used method of assessing
the extent of myocardial damage (2-9). Experimental stud-
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ies (1,4) have shown that infarct size determi ned from CK
release d into the serum correlates closely with that deter-
mined by myocardial CK depletion and by morphologic
features in dogs after 24 hours of coronary occlusion. Stud-
ies of acute myocardial infarction in human subjects have
demonstrated reasonable agreement between infarct size es-
timated by serum CK analysi s and prognosis (2,3), left ven-
tricular hemodynamics (5) and postmortem measurement of
infarct size (5) . Estimation has been improved by quanti-
fying the CK-MB isoenzyme (4). Recent studies comparing
infarct size estimated from serum CK-MB release with other
independent descriptors of infarct size , such as left ventric-
ulography (6), myocardial emission computed tomography
with thallium-201 (7) or positron emission tomography with
C- I l - labeled palmitate (8), have added support to these ob-
servations. In a study performed by Grande et al. (9), infarct
size was estimated from CK-MB release and correlated closely
with morphologic estimates obtained in 22 patients who died
a mean of 6.4 days after myocardial infarction. Thus , the
majority of data indicate that the CK-MB system has at least
semiquantitative validity in human subjects, although the
experimental and mathematical basis for the enzymatic models
as a measure of infarct size has been a matter of controversy
(31-34) .
Effects of cor onar y artery r eper fusion on infar ct size
calcula ted fr om ser um CK-MB release. In our patients
with successful thrombolysis serum CK-MB activity in-
creased sharply immediately after recanalization and reached
a peak after the onset, significantly earlier than occurred in
patients with unsuccessful thrombolysis (Fig. 2 and 3). This
finding is in agreement with the results of prior animal
studies (17-19) and recent clinical studies (11, 12,15 ,16)
suggesting that acute reperfusion washes CK or CK-M B
into the blood . Seria l changes in total serum CK activity
may be distorted because of potential release of CK from
noncard iac sources after cardiac catheterization (35). There -
fore, we analyzed serum CK-MB time-activity curves to
assess the influence of thrombolysis on enzyme release from
the myocardium. The shape of the serum CK-MB time-
activity curve depends not only on the rate of release but
also on the CK-MB disappearance rate (36). In this study,
however, the mean CK-MB disappearance rate in patients
with successful recanalization was similar to that in patients
with unsuccessful recanalization (Table I). In patients with
unsucce ssful recanalization. an excellent linear relation was
observed between lCK-MB and infarct volume estimated
by myocardial emission tomography with thallium-201
(r = 0.91) . Although the relation remained linear even in
patient s with successful recanalization (r = 0.80) , it was
shifted because of relati vely greater CK-MB release into the
blood at a given infarct volume estimated by myocardial
emission tomography with thallium-20 1 (Fig. 4).
In experimental dogs with coronary artery reperfusion ,
the relation between histologic extent of infarction and en-
zymatic estimate was studied by several investigators . Jar-
makani et al. (18) noted early appearance of CK after re-
perfusion and showed the possible effects on CK release of
reperfu sion. distorting infarct size calculations. Vatner et
al. (19) showed that the enzymatic estimate of infarct size
correlated closely (r = 0 .94) when the coronary vessel was
permanently occluded. They also repo rted that these est i-
mates correlated significantly (r = 0 .90) even after reper-
fusion, althoug h the enzymatic values were greater than
expected for the histologic infarct size . because early re-
perfusion may facilitate enzyme washout from infarcted
myocardium. It has been shown that cardiac lymphatics are
the major escape route of myocardial enzymes to the dis-
tribution space and CK is inactivated in lymph (37 ,38) .
Occlusion of cardiac lymphatics induced during myocardial
infarction results in a 50% decrease of the amount of CK
appearing in blood (38) . Therefore, it would be reasonable
to postulate that more rapid transport of CK into the systemic
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circulation due to reperfusion results in relatively less local
degradation of CK and an increase in the amount of CK
released into the blood.
In contrast to experimental data (19), alternations of the
ratio of ~CK-MB to infarct size estimated by myocardial
emission tomography with thallium-201 in the present study
have a wide variation, indicating that the degree of reper-
fusion achieved by thrombolysis is quite inconstant. Factors
determining the degree of washout effect are the timing of
reperfusion and the amount of blood delivered to the in-
farcted area. Experimental reperfusion could be achieved
by properly timed and complete release of a mechanical
obstruction. In patients who underwent intracoronary throm-
bolysis, these are likely to be more variable than in animal
models because of differences in the degree of residual
coronary stenosis and the duration of ischemia. Therefore,
varying degrees of reperfusion achieved by thrombolysis
could result in variation of recovery of the enzyme in blood.
Moreover, experimental reperfusion leads to reactive hy-
peremia (17,39), whereas our technique results in gradual
restoration of flow without reactive hyperemia. These fac-
tors may account for the differences between our results and
data from animal studies .
Limitations of the study. The limitations of myocardial
emission tomography with thallium-201 used as a method
to estimate infarct size in this study must be considered.
Experimental studies have shown that myocardial uptake of
thallium-201 correlates inversely with myocardial creatine
kinase depletion (22) and relative decrease of myocardial
blood flow (20). Necrotic tissue fails to accumulate thallium-
20 I (21). Defects identified by imaging performed at rest
in stable patients usually represent myocardial scar rather
than ischemia (25). However, thallium-201 perfusion de-
fects undoubtedly change with time (23,24). It is possible
that thallium-201 defects in the early stage of infarction
represent ischemic as well as necrotic tissue. The greatest
changes were noted 4 to 11 days after the onset of infarction
(23). To minimize this problem and estimate the final size
of necrotic myocardium, myocardial tomograms were ob-
tained at rest 4 weeks after the onset in stable patients with
a first myocardial infarction . The close correlation between
CK-MB release and tomographic estimate in this study sug-
gests that myocardial ischemia does not playa large role .
Clinically, it would be useful to express scintigraphic
infarct size as a percent of left ventricle infarcted (24.25).
However, because the enzymatic estimate in this study was
presented as an absolute value (the quantity of CK-MB
released) rather than as an index of the proportion of the
left ventricle infarcted (3,6-9), the estimated size by emis-
sion tomography was expressed as infarct volume, which
could be compared with ~CK-MB .
The major advantage of emission tomography is in elim-
inating radioactivity from superimposed structures and mak-
ing improved quantification possible. Accurate attenuation
correction is not available at this time: however, recent
animal studies have shown that emission tomographic im-
aging of thallium-20l is accurate in measuring viable or
infarcted myocardial mass (40) and that the emission tomo-
graphic system accurately reflects regional distribution of
myocardial blood flow (41). Although the definition of
boundaries of infarcted myocardium may have limitations,
our previous reports showed that this approach can provide
improved quantification of the extent of perfusion abnor-
malities (7) as well as improved detection of perfusion de-
fects (29) in comparison with planar imaging in phantom
and clinical studies.
Recently, thallium-201 myocardial scintigraphy has been
used to assess the effect of intracoronary thrombolysis on
myocardial salvage (11,14-16) . It is beyond the scope of
the present study to answer the crucial question whether
early thrombolysis can preserve the myocardial structure.
There was no statistically significant group difference in
infarct volume estimated by emission tomography with thal-
lium-201. Myocardial emission tomography can provide
geometrically reliable three-dimensional distribution of thal-
lium-201. We feel encouraged to apply this procedure to
assessment of the effectiveness of further randomized trials
of thrombolysis in evolving acute myocardial infarction.
Clinical implications. The finding that successful re-
canalization alters the relation between accumulated release
of CK-MB and infarct size indicates the need for caution
in interpreting enzymatic analysis . In patients with acute
myocardial infarction, early spontaneous reperfusion may
occur from reopening of the occluded vessel, native col-
lateral flow, reversal of spasm and various interventions
during the period ofCK release. DeWood et al. (42) reported
that in a substantial number of patients, recanalization oc-
curs within the first 24 hours. In the present study, spon-
taneous recanalization of the infarct-related vessel was ob-
served in four patients and they had early peak of the CK-
MB curves. Under these conditions, the enzymatic values
may overestimate the extent of myocardial injury.
In conclusion, successful thrombolysis alters the kinetics
of CK-MB release, resulting in relatively greater CK-MB
release into the serum at a given infarct size estimated by
myocardial emission tomography with thallium-201. Thus,
serum CK-MB time-activity curves after acute myocardial
infarction may be influenced considerably by acute reper-
fusion, one important factor that should be incorporated
when interpreting enzymatic estimates of infarct size. This
fact should also be noted in cases of spontaneous reperfusion
after acute myocardial infarction.
We gratefully thank Joseph Nicholson for his assistance in preparation of
this manuscript
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